...
PRTCSMALL

PureTech Health plc

HealthcareBiotechnology
$16.77
$0.00(+0.72%)
52W$13.30
$20.00
FinancialsValuationvs REGN
Updated Mar 2, 12:00 AM
RSI39
RS Rating40/99
Beta0.60
Volatility54%
F-Score6/9
Mkt Cap$405M
WEAKENING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

WEAKENING

PureTech Health plc is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 40), showing significant lag compared to the market leaders. Earnings contraction of 27% provides fundamental context to the price action. Investors should exercise caution due to high volatility (54% annualized), which requires wider risk management.

Relative Strength
40
out of 99
Lagging
Trend Score
1/4
Minervini Criteria
WEAKENING
Risk (Beta)
0.60
vs S&P 500
DEFENSIVE
52W Position
52%
from 52W low
Mid Range
Trend & Momentum Analysis

Trend Template (Minervini)

WEAKENING1/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$17.76
50 SMA > 100 SMA$17.43
100 SMA > 150 SMA$17.47
150 SMA > 200 SMA$17.65

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$17.83-5.93%BELOW
50 SMA$17.76-5.58%BELOW
100 SMA$17.43-3.80%BELOW
150 SMA$17.47-4.00%BELOW
200 SMA$17.65-4.98%BELOW

Price Performance

1D+0.7%
1W-3.6%
1M-10.2%
3M+0.4%
6M-3.3%
YTD+0.8%
1Y-5.8%
3Y-16.7%
52-Week Trading Range52% from low
$16.77
52W Low$13.30
52W High$20.00

Technical Indicators

RSI (14)BEARISH
38.6
305070
VCP ScoreCOOL
6/10
Base depth: 23.3%

Risk Profile

Beta
0.60
52W Vol
54%
ATR
$0.59
Max DD (1Y)
-32%

Volume Analysis

Today
16
50D Avg
1.9K
Vol Ratio
0.01x
Liquidity
ILLIQUID

Earnings Momentum

Q4'23-400%
$-0.75
Q2'24-200%
$-1.50
Q4'24+975%
$3.50
Q2'25-322%
$-1.90
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+9.15%
5 Years:-11.09%
3 Years:-21.50%
TTM:-79.43%

Compounded Profit Growth

10 Years:—
5 Years:-32.62%
3 Years:—
TTM:+40.91%

Stock Price CAGR

10 Years:-7.97%
5 Years:-21.07%
3 Years:-16.68%
1 Year:-5.79%

Return on Equity

10Y Avg:2.2%
5Y Avg:-3.7%
3Y Avg:-3.2%
Last Year:-8.5%

Key Metrics

Market Cap$405M
Gross Margin26.0%
Net Margin11.1%
Piotroski F-Score6/9

More PRTC Analysis

Full Financial AnalysisDCF & Intrinsic ValueTotal Return Calculator

Compare With

PRTC vs REGNREGNCNTAIMNMCLDX

Data Dictionary

RS Rating (Relative Strength)

Measures 12-month price performance vs all stocks. Rating of 40 meansPRTC outperformed 40% of all stocks. Scores >80 indicate market leaders.

Beta

Measures volatility vs S&P 500. Beta of 0.60 means 40% less volatile than market.

Piotroski F-Score

9-point financial strength score based on profitability, leverage, and efficiency. Score of 6/9. Scores 7-9 = strong, 4-6 average, 0-3 = weak.

VCP (Volatility Contraction Pattern)

Measures base formation quality. Higher scores indicate tighter consolidation near pivot points. Score of 6/10 with COOL status.

Frequently Asked Questions

Is PRTC in an uptrend right now?

PRTC has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.

Is PRTC overbought or oversold?

PRTC's RSI (14) is 39. The stock is in neutral territory, neither overbought nor oversold.

Is PRTC outperforming the market?

PRTC has a Relative Strength (RS) Rating of 40 out of 99. PRTC is currently lagging the broader market.

Where is PRTC in its 52-week range?

PRTC is trading at $16.77, which is 84% of its 52-week high ($20.00) and 52% above its 52-week low ($13.30).

How volatile is PRTC?

PRTC has a Beta of 0.60 and 52-week volatility of 54%. It's less volatile than the S&P 500 - generally more stable.